CAREIUM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.7 SEK | -1.33% |
|
+2.41% | +28.57% |
| Apr. 25 | Transcript : Careium AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Careium AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Ratings chart - Surperformance
Sector: Business Support Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +28.57% | 66.67M | - | ||
| +5.66% | 14.46B | C+ | ||
| +10.11% | 5.74B | B- | ||
| -22.26% | 2.04B | - | D+ | |
| -5.00% | 957M | B+ | ||
| -3.54% | 821M | B | ||
| -6.66% | 731M | C | ||
| +64.15% | 557M | - | - | |
| -22.02% | 500M | - | - | |
| +4.09% | 497M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
- Stock Market
- Equities
- CARE Stock
- Ratings Careium AB
